<DOC>
	<DOC>NCT01521767</DOC>
	<brief_summary>A Single-Dose Pharmacokinetics And Relative Bioavailability Study Of Tolterodine From Two Microspheres In Powder Blend Extended Release Formulations Compared To The Commercial Extended Release Capsules</brief_summary>
	<brief_title>Pharmacokinetics and Relative Bioavailability Study</brief_title>
	<detailed_description>Pharmacokinetics And Relative Bioavailability Study Of Tolterodine From Two Microspheres In Powder Blend Extended Release Formulations Compared To The Commercial Extended Release Capsules</detailed_description>
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Healthy male and/or female subjects between the ages of 21 and 55 years, inclusive Evidence or history of clinically significant diseases</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>relative bioavailability</keyword>
	<keyword>tolterodine microspheres in powder blend</keyword>
	<keyword>Overactive Urinary Bladder</keyword>
</DOC>